U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Riluzole Oral Suspension
Status: Currently in Shortage
»Date first posted: 01/26/2024
»Therapeutic Categories: Neurology

Expand all

EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) (Reverified 12/02/2024)

Company Contact Information:
610-937-6172

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-2) Unavailable Next release not available at this time; Shortage per Manufacturer: Product manufacturing interrupted due to viscosity testing Requirements related to complying with good manufacturing practices
Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1) Available
Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1) Available
Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1) Available
Back to Top